Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey

@article{Schindler2015IndoleamineHI,
  title={Indoleamine Hallucinogens in Cluster Headache: Results of the Clusterbusters Medication Use Survey},
  author={Emmanuelle A. D. Schindler and Christopher H. Gottschalk and Marsha J Weil and Robert E. Shapiro and Douglas A Wright and Richard Andrew Sewell},
  journal={Journal of Psychoactive Drugs},
  year={2015},
  volume={47},
  pages={372 - 381}
}
Cluster headache is one of the most debilitating pain syndromes. [...] Key Method Participants were recruited from cluster headache websites and headache clinics. The final analysis included responses from 496 participants. The survey was modeled after previously published surveys and was available online. Most responses were chosen from a list, though others were free-texted. Conventional abortive and preventative medications were identified and their efficacies agreed with those previously published. The…Expand
Psychoactive substances as a last resort—a qualitative study of self-treatment of migraine and cluster headaches
TLDR
Psilocybin, lysergic acid diethylamide, and related psychedelic tryptamines were reportedly effective for both prophylactic and acute treatment of cluster headache and migraines and treatment results with cannabis were more unpredictable. Expand
Drug profile: galcanezumab for prevention of cluster headache
TLDR
The negative trial results of galcanezumab for chronic cluster headache may be due to the refractory nature and sheds light on the critical need to investigate the underlying biology and therapeutic options. Expand
Peptides, MAbs, Molecules, Mechanisms, and More: Taking a Stab at Cluster Headache.
TLDR
Recent therapeutic advances in the treatment of cluster headache such as monoclonal antibodies as well as non-invasive vagus nerve stimulation are highlighted, and future potential therapeutic targets are examined. Expand
Clinical applications of hallucinogens: A review.
TLDR
This review will present data on several classes of hallucinogens with a particular focus on psychedelics, entactogens, and dissociatives, for which clinical utility has been most extensively documented, with important ramifications for their potential therapeutic value. Expand
Modern Clinical Research on LSD
  • M. Liechti
  • Psychology, Medicine
  • Neuropsychopharmacology
  • 2017
TLDR
All modern clinical studies using the classic hallucinogen lysergic acid diethylamide in healthy subjects or patients in the last 25 years are reviewed herein and should contribute to further investigations of the therapeutic potential of LSD in psychiatry. Expand
Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review
TLDR
Evidence supports that patients with life threatening diseases associated with symptoms of depression and anxiety benefit from the anxiolytic and antidepressant properties of serotonergic hallucinogens. Expand
Can Psychedelics Alleviate Symptoms of Cluster Headache and Accompanying Mental Health Problems? A Case Report Involving Hawaiian Baby Woodrose
TLDR
Preliminary evidence supports the efficacy of psychedelics in the alleviation of cluster headache and mental health problems and the first case report to concurrently examine the analgesic and psycho-spiritual effects of Hawaiian baby woodrose is described. Expand
Cluster headache: state of the art of pharmacological treatments and therapeutic perspectives
TLDR
Cluster headache (CH) is the most common form of trigeminal autonomic cephalalgia, and no brand‐new treatment has emerged in the past 5 years, but promising drugs, such as CGRP(R) antibodies, are under study. Expand
Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin
TLDR
There is an enduring therapeutic effect in migraine headache after a single administration of psilocybin, urging further investigation into the mechanism underlying the clinical effects of select 5-HT 2A receptor compounds in migraine, as well as other neuropsychiatric conditions. Expand
Neuroendocrine Associations Underlying the Persistent Therapeutic Effects of Classic Serotonergic Psychedelics
TLDR
The effects that psychedelic drugs have on certain structural and functional neuroendocrinological pathologies associated with neuropsychiatric disorders and cluster headache are reviewed and preliminary support for potential long-term effects is provided. Expand
...
1
2
3
...

References

SHOWING 1-10 OF 54 REFERENCES
The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series
TLDR
This study investigates the efficacy of a nonhallucinogenic analog of LSD, BOL-148, which has been studied in volunteers and in patients suffering from vascular headaches but not, apparently, in patients with CH. Expand
Treatment of acute cluster headache with sumatriptan. The Sumatriptan Cluster Headache Study Group.
  • Medicine
  • The New England journal of medicine
  • 1991
TLDR
Sumatriptan is an effective and well-tolerated treatment for acute attacks of cluster headache and was well tolerated in patients with cluster headache. Expand
Oral zolmitriptan is effective in the acute treatment of cluster headache
To the Editor: I read with interest the trial by Bahra et al.1 on the treatment of acute cluster headache with oral zolmitriptan, in which they found a modest but significant difference between theExpand
Serotonergic hallucinogens and emerging targets for addiction pharmacotherapies.
  • S. Ross
  • Medicine
  • The Psychiatric clinics of North America
  • 2012
TLDR
Serotonergic hallucinogen-assisted psychotherapy treatment paradigms for SUDs represent a potential paradigmatic shift within the field of psychiatry and would truly constitute a novel psychopharmacologic-psychosocial treatment paradigm to treat addictive disorders. Expand
Cluster headache: pathogenesis, diagnosis, and management
TLDR
Time to diagnosis of cluster headache has improved, probably the result of a better understanding of the pathophysiology in combination with efficient treatment strategies, leading to a broader acceptance of the syndrome by doctors. Expand
Treatment of acute cluster headache with 20 mg sumatriptan nasal spray – an open pilot study
TLDR
It is concluded that 20 mg sumatriptan nasal spray might be an alternative therapy for the treatment of cluster headache attacks, but double-blind studies are needed to further evaluate its efficacy. Expand
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
TLDR
In a controlled clinical environment, psilocybin was safely used in subjects with OCD and was associated with acute reductions in core OCD symptoms in several subjects. Expand
Hypothalamic stimulation in chronic cluster headache: a pilot study of efficacy and mode of action.
TLDR
It is concluded that hypothalamic stimulation has remarkable efficacy in most, but not all, patients with treatment-resistant chronic cluster headache, and is not due to a simple analgesic effect or to hormonal changes. Expand
Hallucinogens and dissociative agents naturally growing in the United States.
  • J. Halpern
  • Medicine, Chemistry
  • Pharmacology & therapeutics
  • 2004
TLDR
This article reviews plants containing N,N-dimethyltryptamine, reversible type A monoamine oxidase inhibitors (MAOI), lysergic acid amide, the anticholinergic drugs atropine and scopolamine, or the diterpene salvinorin-A (Salvia divinorum), and includes information on the geographical range, drug content, preparation, intoxication, and the special health risks associated with some of these plants. Expand
Response of cluster headache to psilocybin and LSD
TLDR
The authors interviewed 53 cluster headache patients who had used psilocybin or lysergic acid diethylamide (LSD) to treat their condition to find out whether these patients had aborted attacks or reported remission period extension. Expand
...
1
2
3
4
5
...